Compare Orchid Pharma with Fulford India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA vs FULFORD INDIA - Comparison Results

ORCHID PHARMA     Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA FULFORD INDIA ORCHID PHARMA/
FULFORD INDIA
 
P/E (TTM) x -163.5 398.8 - View Chart
P/BV x 46.9 6.2 754.4% View Chart
Dividend Yield % 0.0 0.1 -  

Financials

 ORCHID PHARMA   FULFORD INDIA
EQUITY SHARE DATA
    ORCHID PHARMA
Sep-13
FULFORD INDIA
Mar-14
ORCHID PHARMA/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs194942 20.6%   
Low Rs35450 7.8%   
Sales per share (Unadj.) Rs276.5691.4 40.0%  
Earnings per share (Unadj.) Rs-79.211.5 -691.1%  
Cash flow per share (Unadj.) Rs-43.515.4 -282.9%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.3 0.0%  
Book value per share (Unadj.) Rs53.9380.0 14.2%  
Shares outstanding (eoy) m70.453.90 1,806.4%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.41.0 41.1%   
Avg P/E ratio x-1.460.7 -2.4%  
P/CF ratio (eoy) x-2.645.3 -5.8%  
Price / Book Value ratio x2.11.8 115.9%  
Dividend payout %017.4 0.0%   
Avg Mkt Cap Rs m8,0672,714 297.2%   
No. of employees `0002.80.4 630.6%   
Total wages/salary Rs m2,527505 500.4%   
Avg. sales/employee Rs Th6,956.16,073.0 114.5%   
Avg. wages/employee Rs Th902.51,137.4 79.3%   
Avg. net profit/employee Rs Th-1,993.0100.7 -1,979.6%   
INCOME DATA
Net Sales Rs m19,4772,696 722.3%  
Other income Rs m407125 324.7%   
Total revenues Rs m19,8842,822 704.7%   
Gross profit Rs m1,103-46 -2,376.3%  
Depreciation Rs m2,51915 16,573.7%   
Interest Rs m5,22710 55,018.9%   
Profit before tax Rs m-6,23654 -11,484.7%   
Minority Interest Rs m200-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m5110-   
Tax Rs m-12510 -1,304.2%   
Profit after tax Rs m-5,58045 -12,483.9%  
Gross profit margin %5.7-1.7 -329.0%  
Effective tax rate %2.017.7 11.4%   
Net profit margin %-28.71.7 -1,728.3%  
BALANCE SHEET DATA
Current assets Rs m11,0141,738 633.6%   
Current liabilities Rs m32,060545 5,885.9%   
Net working cap to sales %-108.144.3 -244.1%  
Current ratio x0.33.2 10.8%  
Inventory Days Days9548 195.8%  
Debtors Days Days344 779.5%  
Net fixed assets Rs m29,44012 247,394.1%   
Share capital Rs m70539 1,806.4%   
"Free" reserves Rs m2,0431,443 141.6%   
Net worth Rs m3,8001,482 256.4%   
Long term debt Rs m9,0180-   
Total assets Rs m46,5102,077 2,239.6%  
Interest coverage x-0.26.7 -2.9%   
Debt to equity ratio x2.40-  
Sales to assets ratio x0.41.3 32.3%   
Return on assets %-0.82.6 -29.1%  
Return on equity %-146.93.0 -4,868.8%  
Return on capital %-3.74.3 -86.8%  
Exports to sales %37.90-   
Imports to sales %22.624.5 92.5%   
Exports (fob) Rs m7,378NA-   
Imports (cif) Rs m4,406659 668.3%   
Fx inflow Rs m7,51317 43,682.0%   
Fx outflow Rs m5,649673 839.1%   
Net fx Rs m1,865-656 -284.2%   
CASH FLOW
From Operations Rs m1,68290 1,868.6%  
From Investments Rs m-9,860105 -9,426.8%  
From Financial Activity Rs m6,644-14 -47,119.1%  
Net Cashflow Rs m-1,535181 -850.4%  

Share Holding

Indian Promoters % 32.3 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 4.6 3.8 121.1%  
FIIs % 3.3 0.1 3,300.0%  
ADR/GDR % 4.6 0.0 -  
Free float % 55.3 21.2 260.8%  
Shareholders   84,811 4,783 1,773.2%  
Pledged promoter(s) holding % 54.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA With:   CADILA HEALTHCARE  TTK HEALTHCARE  SHASUN PHARMA  BIOCON   J.B.CHEMICALS  

Compare ORCHID PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 154 Points Lower, Nifty Ends at 14,834; Bajaj Finance and UPL Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended marginally lower.

Related Views on News

Most Popular

A Critical Update on the Market(Fast Profits Daily)

Mar 30, 2021

In this video, I'll tell you why I am recommending caution in the market at this time.

My Recent Recommendation Will Profit from the Global Supply Chain Crisis(Profit Hunter)

Mar 31, 2021

A tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.

My Stock Trading Strategy(Fast Profits Daily)

Mar 31, 2021

In this video I'll show you exactly how I go about picking stocks for trading.

What You Need to Find Hundred Baggers(Profit Hunter)

Mar 30, 2021

100 baggers of the last decade share this common trait. Here's how to use it to nail future multibaggers.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA SHARE PRICE


Apr 9, 2021 (Close)

TRACK ORCHID PHARMA

  • Track your investment in ORCHID PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ORCHID PHARMA 5-YR ANALYSIS

COMPARE ORCHID PHARMA WITH

MARKET STATS